{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "c.157G>A (p.Ala53Thr)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson Disease",
    "MONDO": "MONDO:0005291"
  },
  "Experiment Method": [
    {
      "Assay Method": "Allele-Specific Expression Analysis",
      "Material used": {
        "Material Source": "Lymphoblastoid cell lines and blood cells",
        "Material Name": "Patient-derived cells",
        "Description": "Analysis of SNCA expression in lymphoblastoid cell lines and blood cells from a heterozygous patient with p.Ala53Thr mutation."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Epigenetic silencing of mutant allele",
          "Result Description": "Monoallelic expression of SNCA with epigenetic silencing of the mutant allele and upregulation of the wild-type allele compared to control individuals."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SNCA allele expression in control individuals."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Silenced mutant allele expression in the patient."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D. (Custom threshold for normal/abnormal expression)"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal expression levels observed in control individuals (no specific threshold provided).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal expression levels defined by monoallelic expression and epigenetic silencing of the mutant allele (no specific threshold provided).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}